|
|
||||||||
Ann Thorac Surg 2002;74:2010-2015
© 2002 The Society of Thoracic Surgeons
a Department of Echocardiography, Hôpital Cardiologique, Centre Hospitalier Régional et Universitaire de Lille, 59037 Lille Cedex, France
b Department of Cardiac Surgery, Hôpital Cardiologique, Centre Hôpitalier Régional et Universitaire de Lille, Lille, France
Accepted for publication July 12, 2002.
* Address reprint requests to Dr Le Tourneau, Department of Echocardiography, Hôpital Cardiologique, Boulevard du Professeur J. Leclerc, 59037 Lille Cedex, France.
e-mail: thletourneau{at}yahoo.fr
BACKGROUND: There are little comparative data on Carpentier-Edwards supraannular and pericardial second-generation bioprostheses. The aim of this work was to compare their hemodynamic and clinical outcomes in patients with aortic stenosis.
METHODS: We conducted a retrospective study including 150 patients operated on for aortic stenosis between 1989 and 1993. Patients undergoing aortic valve replacement with either a Carpentier-Edwards supraannular or pericardial prosthesis were matched for sex (49% male), age (72 ± 8 years), body surface area, valve size, associated procedures, and left ventricular ejection fraction.
RESULTS: Mean follow-up was 6.5 ± 3.3 years, giving a total follow-up of 983 patient-years. Thirty-day mortality and 10-year actuarial survival were, respectively, 8% and 51% in the supraannular group and 6.7% and 43.4% in the pericardial group. At 10 years, freedom from thromboembolism, structural failure, and all valve-related events were, respectively, 88.7%, 88.9%, and 68.7% in the supraannular group and 85%, 100%, and 82.2% in the pericardial group. There were four (5.3%) structural failures, and four (5.3%) reoperations for degeneration (n = 3) and endocarditis (n = 1) in the supraannular group. Freedom from structural dysfunction or reoperation was 87.3% in the supraannular group and 100% (p < 0.05) in the pericardial group. Echocardiographic review of 62 of 76 survivors (81.5%) demonstrated a trend toward a better hemodynamic profile of pericardial valves at the end of follow-up.
CONCLUSIONS: Ten years after aortic valve replacement for aortic stenosis, Carpentier-Edwards pericardial prostheses give comparable and probably better results than Carpentier-Edwards supraannular prostheses.
This article has been cited by other articles:
![]() |
S. Narang, D. K. Satsangi, A. Banerjee, and M. A. Geelani Stentless valves versus stented bioprostheses at the aortic position: midterm results. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 943 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ali, J. C. Halstead, F. Cafferty, L. Sharples, F. Rose, R. Coulden, E. Lee, J. Dunning, V. Argano, and S. Tsui Are Stentless Valves Superior to Modern Stented Valves?: A Prospective Randomized Trial Circulation, July 4, 2006; 114(1_suppl): I-535 - I-540. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lund and M. Bland Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bottio, G. Rizzoli, G. Thiene, G. Nesseris, D. Casarotto, and G. Gerosa Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: An 8-year experience J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1616 - 1623. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |